Skip to Content
Merck
  • ARF6 Is an Actionable Node that Orchestrates Oncogenic GNAQ Signaling in Uveal Melanoma.

ARF6 Is an Actionable Node that Orchestrates Oncogenic GNAQ Signaling in Uveal Melanoma.

Cancer cell (2016-06-07)
Jae Hyuk Yoo, Dallas S Shi, Allie H Grossmann, Lise K Sorensen, ZongZhong Tong, Tara M Mleynek, Aaron Rogers, Weiquan Zhu, Jackson R Richards, Jacob M Winter, Jie Zhu, Christine Dunn, Ashok Bajji, Mark Shenderovich, Alan L Mueller, Scott E Woodman, J William Harbour, Kirk R Thomas, Shannon J Odelberg, Kirill Ostanin, Dean Y Li
ABSTRACT

Activating mutations in Gαq proteins, which form the α subunit of certain heterotrimeric G proteins, drive uveal melanoma oncogenesis by triggering multiple downstream signaling pathways, including PLC/PKC, Rho/Rac, and YAP. Here we show that the small GTPase ARF6 acts as a proximal node of oncogenic Gαq signaling to induce all of these downstream pathways as well as β-catenin signaling. ARF6 activates these diverse pathways through a common mechanism: the trafficking of GNAQ and β-catenin from the plasma membrane to cytoplasmic vesicles and the nucleus, respectively. Blocking ARF6 with a small-molecule inhibitor reduces uveal melanoma cell proliferation and tumorigenesis in a mouse model, confirming the functional relevance of this pathway and suggesting a therapeutic strategy for Gα-mediated diseases.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
NAV-2729, ≥98% (HPLC)